Janux Therapeutics (JANX) had the highest return in February 2024 by a mid-cap US stock, returning 456.1%.

ASSET	MONTH	% RETURN
Janux Therapeutics (JANX)	February 2024	456.09%
SoundHound AI (SOUN)	February 2024	336.47%
Viking Therapeutics (VKTX)	February 2024	217.08%
GeneDx (WGS)	February 2024	111.69%
D-Wave Quantum (QBTS)	February 2024	107.87%
CleanSpark (CLSK)	February 2024	106.42%
Iovance Biotherapeutics (IOVA)	February 2024	102.68%
Lifestance Health (LFST)	February 2024	75.79%
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) (PSNYW)	February 2024	63.64%
Celsius (CELH)	February 2024	63.24%
Beam Therapeutics (BEAM)	February 2024	60.79%
Powell Industries (POWL)	February 2024	54.64%
Vizio (VZIO)	February 2024	54.63%
Hims Hers Health (HIMS)	February 2024	51.63%
Revolve Group LLC (RVLV)	February 2024	50%
Iris Energy (IREN)	February 2024	49.37%
Confluent (CFLT)	February 2024	49.08%
Avidity Biosciences (RNA)	February 2024	48.66%
Arlington Asset Investment (AI)	February 2024	48.41%
Rigetti Computing (RGTI)	February 2024	46.88%
Purecycle Technologies (PCT)	February 2024	46.58%
Marathon Digital (MARA)	February 2024	45.83%
PureCycle Technologies (PCTTW)	February 2024	44.27%
Krystal Biotech (KRYS)	February 2024	42.43%
Recursion Pharmaceuticals (RXRX)	February 2024	41.39%

Mid-cap stocks are treated as having a market cap between $2B and $10B.